Friday, November 22 2024

IMAC Holdings’ public standing threatened by Nasdaq delisting letters

firststargroup November 29, 2023

Jabil acquires electronics, semiconductor reclamation company in push for sustainability

firststargroup November 7, 2023

Bridge to Equity: Addressing the social determinants of health

firststargroup July 7, 2023

Former Silicon Valley Bank executive pleads guilty to falsifying letters of support

firststargroup February 8, 2023

With Genentech deal and funding round, Belharra Therapeutics looks to ride next wave of drug development

firststargroup January 5, 2023

Equitable Mortgage Corp. to sell Columbus office, relocate to Dublin’s Metro Center

firststargroup August 19, 2022

Here are Ohio’s 50 most-promising startups, according to VentureOhio

firststargroup September 1, 2018

Affordable housing development in line for $50M in tax-exempt bond funding

firststargroup October 26, 2023

Eisai shuts down Cambridge-based subsidiary

firststargroup July 19, 2022

H3 Biomedicine Inc., a Cambridge-based cancer biotech owned by Japanese pharmaceutical company Eisai, is shutting down.

About the author

firststargroup

Suggested Posts

Top of the Market: 13-acre estate in Southeast Memphis takes top spot

UW Medicine names interim CEO Dr. Tim Dellit to permanent role

Hunter Fan partners with HGTV star Jasmine Roth for product line

Seattle’s largest community health center names new CEO

Blue Diamond Growers reports $1.61 billion in revenue for 2022 crop year

Tuesday Digest: Bay Area real estate investor’s CEO dies; Apple sets new date for office return

More Stories

HEI reports $204M in net income for 2018

firststargroup February 16, 2019